Ensysce Biosciences, Inc.
ENSC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,987 | -$10,626 | -$24,208 | -$29,146 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $110,723,000 | $879 | $1,072 | $122 |
| Change in WC | -$851 | -$947 | $5,482 | -$1,303 |
| Other Non-Cash | -$7,613,414,162 | -$86 | -$233 | $22,085 |
| Operating Cash Flow | -$7,502,700,000 | -$10,780 | -$17,887 | -$8,242 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $5 | $0 |
| Investing Cash Flow | $0 | $0 | $5 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$485 | $605 | $6,126 | $13,912 |
| Stock Issued | $1,670 | $9,050 | $3,783 | $6,626 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$290,000 | $0 | $0 | $0 |
| Other Fin. Act. | $9,881,461,815 | -$900 | -$1,143 | -$226 |
| Financing Cash Flow | $9,881,173,000 | $8,756 | $8,766 | $20,313 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2,378,473,000 | -$2,024 | -$9,117 | $12,071 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,123,604,000 | $3,148 | $12,265 | $194 |
| End Cash | $3,502,077,000 | $1,124 | $3,148 | $12,265 |
| Free Cash Flow | -$7,502,700,000 | -$10,780 | -$17,887 | -$8,242 |